Welcome to LookChem.com Sign In|Join Free
  • or
3-[4-(METHYLSULFANYL)PHENYL]ACRYLIC ACID, with the molecular formula C10H10O2S, is a unique chemical compound belonging to the acrylic acid family. It features a 4-(methylsulfanyl)phenyl group attached to the carbon-carbon double bond in the acrylate moiety, which endows it with distinctive chemical and physical properties. This versatile compound is widely utilized in the synthesis of polymers, adhesives, and coatings, and also holds promise in medicinal chemistry and pharmaceutical synthesis.

102016-58-0

Post Buying Request

102016-58-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

102016-58-0 Usage

Uses

Used in Polymer Production:
3-[4-(METHYLSULFANYL)PHENYL]ACRYLIC ACID is used as a monomer in the production of polymers for its ability to contribute to the formation of polymers with specific properties, such as enhanced stability and reactivity due to the presence of the methylsulfanyl group.
Used in Adhesive Formulation:
In the adhesive industry, 3-[4-(METHYLSULFANYL)PHENYL]ACRYLIC ACID is used as a key component in formulating adhesives that offer improved bonding strength and durability, leveraging its reactive acrylate moiety and the unique characteristics of the methylsulfanyl group.
Used in Coating Development:
3-[4-(METHYLSULFANYL)PHENYL]ACRYLIC ACID is utilized in the development of coatings, where it serves to enhance the performance of the coating by providing properties such as increased resistance to environmental factors and improved adhesion to various substrates.
Used in Medicinal Chemistry:
3-[4-(METHYLSULFANYL)PHENYL]ACRYLIC ACID is used as a building block in medicinal chemistry for the synthesis of pharmaceuticals, capitalizing on its unique structure to create new compounds with potential therapeutic applications.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, 3-[4-(METHYLSULFANYL)PHENYL]ACRYLIC ACID is employed as an intermediate in the synthesis of various drugs, taking advantage of its reactive sites and the versatility of its chemical structure to produce a range of medicinal compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 102016-58-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,0,1 and 6 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 102016-58:
(8*1)+(7*0)+(6*2)+(5*0)+(4*1)+(3*6)+(2*5)+(1*8)=60
60 % 10 = 0
So 102016-58-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H10O2S/c1-13-9-5-2-8(3-6-9)4-7-10(11)12/h2-7H,1H3,(H,11,12)/b7-4+

102016-58-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-[4-(Methylsulfanyl)Phenyl]Acrylic Acid

1.2 Other means of identification

Product number -
Other names 3-(4-methylsulfanylphenyl)prop-2-enoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:102016-58-0 SDS

102016-58-0Relevant academic research and scientific papers

Dual Nickel/Ruthenium Strategy for Photoinduced Decarboxylative Cross-Coupling of α,β-Unsaturated Carboxylic Acids with Cycloketone Oxime Esters

Lu, Xiao-Yu,Xia, Ze-Jie,Gao, Ang,Liu, Qi-Le,Jiang, Run-Chuang,Liu, Chuang-Chuang

, p. 8829 - 8842 (2021)

Herein, a dual nickel/ruthenium strategy is developed for photoinduced decarboxylative cross-coupling between α,β-unsaturated carboxylic acids and cycloketone oxime esters. The reaction mechanism is distinct from previous photoinduced decarboxylation of α,β-unsaturated carboxylic acids. This reaction might proceed through a nickelacyclopropane intermediate. The C(sp2)-C(sp3) bond constructed by the aforementioned reaction provides an efficient approach to obtaining various cyanoalkyl alkenes, which are synthetically valuable organic skeletons in organic and medicinal chemistry, under mild reaction conditions. The protocol tolerates many critical functional groups and provides a route for the modification of complex organic molecules.

Evaluation of the efficiency of the photocatalytic one-electron oxidation reaction of aromatic compounds adsorbed on a TiO2 surface

Tachikawa, Takashi,Yoshida, Akihiro,Tojo, Sachiko,Sugimoto, Akira,Fujitsuka, Mamoru,Majima, Tetsuro

, p. 5345 - 5353 (2004)

The TiO2 photocatalytic one-electron oxidation mechanism of aromatic sulfides with a methylene bridging group (-(CH2) n-, n = 0-4) between the 4-(methylthio)phenyl chromophore and the carboxylate binding group on the surfa

Ligand-controlled divergent dehydrogenative reactions of carboxylic acids via C–H activation

Wang, Zhen,Hu, Liang,Chekshin, Nikita,Zhuang, Zhe,Qian, Shaoqun,Qiao, Jennifer X.,Yu, Jin-Quan

, p. 1281 - 1285 (2021/12/10)

Dehydrogenative transformations of alkyl chains to alkenes through methylene carbon-hydrogen (C–H) activation remain a substantial challenge. We report two classes of pyridine-pyridone ligands that enable divergent dehydrogenation reactions through palladium-catalyzed b-methylene C–H activation of carboxylic acids, leading to the direct syntheses of a,b-unsaturated carboxylic acids or g-alkylidene butenolides. The directed nature of this pair of reactions allows chemoselective dehydrogenation of carboxylic acids in the presence of other enolizable functionalities such as ketones, providing chemoselectivity that is not possible by means of existing carbonyl desaturation protocols. Product inhibition is overcome through ligand-promoted preferential activation of C(sp3)–H bonds rather than C(sp2)–H bonds or a sequence of dehydrogenation and vinyl C–H alkynylation. The dehydrogenation reaction is compatible with molecular oxygen as the terminal oxidant.

Palladium(II)-Catalyzed Oxidative Decarboxylative [2 + 2 + 1] Annulation of Cinnamic Acids with Alkynes: Access to Polysubstituted Pentafulvenes

Peng, Shiyong,Chen, Nuan,Zhang, Hong,He, Min,Li, Hongguang,Lang, Ming,Wang, Jian

supporting information, p. 5589 - 5593 (2020/07/08)

An unprecedented palladium(II)-catalyzed oxidative decarboxylative [2 + 2 + 1] annulation of cinnamic acids with alkynes has been developed for the synthesis of polysubstituted pentafulvenes. Ag2CO3 and DMSO are essential for the reaction. This protocol features readily available starting materials, a wide substrate scope, and moderate to excellent yields. Moreover, various significant frameworks can be easily obtained from the late-stage transformations of pentafulvenes via oxidation, reduction, and Scholl-type reaction.

N-Hydroxybenzimidazole inhibitors of ExsA MAR transcription factor in Pseudomonas aeruginosa: In vitro anti-virulence activity and metabolic stability

Grier, Mark C.,Garrity-Ryan, Lynne K.,Bartlett, Victoria J.,Klausner, Kevin A.,Donovan, Peter J.,Dudley, Caroline,Alekshun, Michael N.,Ken Tanaka,Draper, Michael P.,Levy, Stuart B.,Kim, Oak K.

scheme or table, p. 3380 - 3383 (2010/08/06)

ExsA is a multiple adaptational response (MAR) transcription factor, regulating the expression of a virulence determinant, the type III secretion system (T3SS) in Pseudomonas aeruginosa. Non-cytotoxic, non-antibacterial N-hydroxybenzimidazoles were identified as effective inhibitors of ExsA-DNA binding, and their potential utility as anti-virulence agents for P. aeruginosa was demonstrated in a whole cell assay. Select N-hydroxybenzimidazole inhibitors were stable in an in vitro human liver microsomal assay.

Antimalarials. Synthesis and antimalarial activity of 1 (4 methoxycinnamoyl) 4 (5 phenyl 4 oxo 2 oxazolin 2 yl)piperazine and derivatives

Herrin,Pauvlik,Schuber,Geiszler

, p. 1216 - 1223 (2007/10/04)

The preparation and activity against Plasmodium berghei of derivatives of 1 (4 methoxycinnamoyl) 4 (5 phenyl 4 oxo 2 oxazolin 2 yl)piperazine are described. Replacement of the cinnamoyl group was accomplished by acylation or alkylation of 1 (5 phenyl 4 oxo 2 oxazolin 2 yl)piperazine. Modifications of the 5 phenyl group were prepared either by a sequence of reactions involving mandelic ester pemoline piperazine pemoline or by the reaction of 5 aryl 2 thio 2,4 oxazolidinedione with piperazine or N substituted piperazines. In a similar manner, pemoline was allowed to react with N arylpiperazine, hexahydro 1H 1,4 diazepine, and 2,6 dimethylpiperazine to provide N arylpiperazine pemoline derivatives and variations in the piperazine moiety. Several compounds in which the 2 oxazolin 4 one ring was replaced with other heterocyclic rings were prepared as were several open chain analogs. Five compounds (three of them substituted in the para position of the 5 phenyl group and two N arylpiperazine pemoline derivatives) were found to be active against Plasmodium berghei. The remaining active compound possessed changes in the cinnamoyl group and substitution on the 5 phenyl group.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 102016-58-0